Malaria remains a major public health issue, particularly in sub-Saharan Africa and Southeast Asia. The use of ACTs has resulted in significant reductions in malaria morbidity and mortality. The rapid action of artemisinin compounds quickly reduces the parasite load, while the partner drug ensures that any remaining parasites are eliminated, reducing the risk of recrudescence and transmission.
